References

​

1. Briggs, R. and T.J. King, Transplantation of Living Nuclei From Blastula Cells into Enucleated Frogs' Eggs. Proc Natl Acad Sci U S A, 1952. 38(5): p. 455-63.

2. Gurdon, J.B., The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. J Embryol Exp Morphol, 1962. 10: p. 622-40.

3. Campbell, K.H., et al., Sheep cloned by nuclear transfer from a cultured cell line. Nature, 1996. 380(6569): p. 64-6.

4. Yang, X., et al., Nuclear reprogramming of cloned embryos and its implications for therapeutic cloning. Nat Genet, 2007. 39(3): p. 295-302.

5. Ethics Committee of the American Society for Reproductive Medicine. Electronic address, A.a.o. and M. Ethics Committee of the American Society for Reproductive, Human somatic cell nuclear transfer and reproductive cloning: an Ethics Committee opinion. Fertil Steril, 2016. 105(4): p. E1-4.

6. Gurdon, J., Harveian Oration 2014: Stem cells and cell replacement prospects. Clin Med (Lond), 2015. 15(2): p. 160-7.

7. Gao, T., et al., Nuclear reprogramming: the strategy used in normal development is also used in somatic cell nuclear transfer and parthenogenesis. Cell Res, 2007. 17(2): p. 135-50.

8. Halley-Stott, R.P., V. Pasque, and J.B. Gurdon, Nuclear reprogramming. Development, 2013. 140(12): p. 2468-71.

​

9. Apostolou, E. and K. Hochedlinger, Chromatin dynamics during cellular reprogramming. Nature, 2013. 502(7472): p. 462-71.

10. Guo, G., et al., Naive Pluripotent Stem Cells Derived Directly from Isolated Cells of the Human Inner Cell Mass. Stem Cell Reports, 2016. 6(4): p. 437-46.

​

11. Brook, F.A. and R.L. Gardner, The origin and efficient derivation of embryonic stem cells in the mouse. Proc Natl Acad Sci U S A, 1997. 94(11): p. 5709-12.

12. Nichols, J. and A. Smith, Naive and primed pluripotent states. Cell Stem Cell, 2009. 4(6): p. 487-92.

13. Tachibana, M., et al., Human embryonic stem cells derived by somatic cell nuclear transfer. Cell, 2013. 153(6): p. 1228-38.

14. Takahashi, K. and S. Yamanaka, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006. 126(4): p. 663-76.

15. Stadtfeld, M. and K. Hochedlinger, Induced pluripotency: history, mechanisms, and applications. Genes Dev, 2010. 24(20): p. 2239-63.

16. Yamanaka, S. and H.M. Blau, Nuclear reprogramming to a pluripotent state by three approaches. Nature, 2010. 465(7299): p. 704-12.

17. Liu, H., et al., Ooplasmic Influence on Nuclear Function During the Metaphase II-Interphase Transition in Mouse Oocytes. Biology of Reproduction, 2001. 65(6): p. 1794-1799.

18. Liu, H., et al., Reconstruction of mouse oocytes by germinal vesicle transfer: maturity of host oocyte cytoplasm determines meiosis. Human Reproduction, 1999. 14(9): p. 2357-2361.

19. Zhang, J. and H. Liu, Cytoplasm replacement following germinal vesicle transfer restores meiotic maturation and spindle assembly in meiotically arrested oocytes. Reprod Biomed Online, 2015. 31(1): p. 71-8.

20. Wakayama, T. and R. Yanagimachi, The first polar body can be used for the production of normal offspring in mice. Biol Reprod, 1998. 59(1): p. 100-4.

21. Wang, T., et al., Polar body genome transfer for preventing the transmission of inherited mitochondrial diseases. Cell, 2014. 157(7): p. 1591-604.

22. Tachibana, M., et al., Mitochondrial gene replacement in primate offspring and embryonic stem cells. Nature, 2009. 461(7262): p. 367-72.

23. Wakayama, T., Y. Hayashi, and A. Ogura, Participation of the female pronucleus derived from the second polar body in full embryonic development of mice. J Reprod Fertil, 1997. 110(2): p. 263-6.

24. Wei, Y., et al., Polar bodies in assisted reproductive technology: current progress and future perspectives. Biol Reprod, 2015. 92(1): p. 19.

25. Zhang, J., Revisiting germinal vesicle transfer as a treatment for aneuploidy in infertile women with diminished ovarian reserve. J Assist Reprod Genet, 2015. 32(2): p. 313-7.

26. Zhang, J., et al., Live birth derived from oocyte spindle transfer to prevent mitochondrial disease. Reprod Biomed Online, 2017. 34(4): p. 361-368.

27. Zhang, S.P., et al., Polar body transfer restores the developmental potential of oocytes to blastocyst stage in a case of repeated embryo fragmentation. J Assist Reprod Genet, 2017. 34(5): p. 563-571.

28. Ma, H., et al., Functional Human Oocytes Generated by Transfer of Polar Body Genomes. Cell Stem Cell, 2017. 20(1): p. 112-119.

29. Craven, L., et al., Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease. Nature, 2010. 465(7294): p. 82-5.

30. Wolf, D.P., N. Mitalipov, and S. Mitalipov, Mitochondrial replacement therapy in reproductive medicine. Trends Mol Med, 2015. 21(2): p. 68-76.

31. Sato, A., et al., Gene therapy for progeny of mito-mice carrying pathogenic mtDNA by nuclear transplantation. Proc Natl Acad Sci U S A, 2005. 102(46): p. 16765-70.

32. Liu, H., et al., The in vitro development of human zygote reconstructed by pronuclear transfer. Fertility and Sterility, 2015. 104(3).

33. Lu, Z., et al., The impact of human oocyte reconstruction using meiosis II spindle transfer on the pre-implantation embryonic development. Fertility and Sterility, 2015. 104(3).

34. Paull, D., et al., Nuclear genome transfer in human oocytes eliminates mitochondrial DNA variants. Nature, 2013. 493(7434): p. 632-7.

35. Lin, T., et al., Chromosomes in the porcine first polar body possess competence of second meiotic division within enucleated MII stage oocytes. PLoS One, 2013. 8(12): p. e82766.

36. Shi, Y., et al., Induced pluripotent stem cell technology: a decade of progress. Nat Rev Drug Discov, 2017. 16(2): p. 115-130.

37. Liu, H., Metaphase II nuclei generated by germinal vesicle transfer in mouse oocytes support embryonic development to term. Human Reproduction, 2003. 18(9): p. 1903-1907.

38. Liu, H., J. Grifo, and L. Krey, Germinal vesicle transfer rescues nuclear maturation from the cytoplasmic defects present in vitro-aged oocytes. Fertility and Sterility, 2003. 80: p. 258-259.

39. H. Liu, L.C.K., J. Zhang, J. A. Grifo., Normal live birth produced from preovulatory mouse oocytes reconstructed by germinal vesicle transfer. Fertil Steril, 2001. 76: p. S56.

40. H. Liu, L.C.K., J. Zhang, J. A. and Grifo, The nuclear developmental capacity of mouse oocytes following cryopreservation at germinal vesicle stage. Fertil Steril, 2001. 76: p. S80.

41. Liu, H., et al., In-vitro development of mouse zygotes following reconstruction by sequential transfer of germinal vesicles and haploid pronuclei. Hum Reprod, 2000. 15(9): p. 1997-2002.

42. H. Liu, J.Z., J. A. Grifo, L. C. Krey, Evaluating the Competency of the Nucleus and Ooplasm of In Vitro Matured, Artificially Activated Oocytes. Fertil Steril, 2000. 74: p. S65-S66.

43. Hui Liu, L. and J.Z. C. Krey, Hungchi Chang, Jamie Grifo, Germinal vesicle xeno-transfer between mouse and human oocytes a model to study ooplasmic influences on meiotic division. Fertil Steril, 2002. 76: p. S77.

44. Chang, H.C., et al., Developmental incompetency of denuded mouse oocytes undergoing maturation in vitro is ooplasmic in nature and is associated with aberrant Oct-4 expression. Hum Reprod, 2005. 20(7): p. 1958-68.

45. Zhang, J., et al., In vitro maturation of human preovulatory oocytes reconstructed by germinal vesicle transfer. Fertil Steril, 1999. 71(4): p. 726-31.

46. Zhang, J., et al., Pregnancy derived from human nuclear transfer. Fertility and Sterility, 2003. 80.

47. Kang, E., et al., Mitochondrial replacement in human oocytes carrying pathogenic mitochondrial DNA mutations. Nature, 2016. 540(7632): p. 270-275.

48. Kamao, H., et al., Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application. Stem Cell Reports, 2014. 2(2): p. 205-18.

49. Mandai, M., et al., Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration. N Engl J Med, 2017. 376(11): p. 1038-1046.

50. First-Ever CAR T-cell Therapy Approved in U.S. Cancer Discov, 2017.

51. Mueller, K.T., et al., Cellular kinetics of CTL019 in relapsed/refractory B-cell acute lymphoblastic leukemia and chronic lymphocytic leukemia. Blood, 2017.

52. Ferrua, F. and A. Aiuti, Twenty-five years of gene therapy for ADA-SCID: from "bubble babies" to an approved drug. Hum Gene Ther, 2017.

53. Elliott, H.R., et al., Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet, 2008. 83(2): p. 254-60.

54. Schaefer, A.M., et al., Prevalence of mitochondrial DNA disease in adults. Ann Neurol, 2008. 63(1): p. 35-9.

55. Gorman, G.S., et al., Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Ann Neurol, 2015. 77(5): p. 753-9.

56. Krey, L., et al., Fertility and maternal age strategies to improve pregnancy outcome. Ann N Y Acad Sci, 2001. 943: p. 26-33.

57. Webster, A. and M. Schuh, Mechanisms of Aneuploidy in Human Eggs. Trends Cell Biol, 2017. 27(1): p. 55-68.

58. Nagaoka, S.I., T.J. Hassold, and P.A. Hunt, Human aneuploidy: mechanisms and new insights into an age-old problem. Nat Rev Genet, 2012. 13(7): p. 493-504.

59. Wang, Z.B., H. Schatten, and Q.Y. Sun, Why is chromosome segregation error in oocytes increased with maternal aging? Physiology (Bethesda), 2011. 26(5): p. 314-25.

60. Chian, R.C., W.M. Buckett, and S.L. Tan, In-vitro maturation of human oocytes. Reprod Biomed Online, 2004. 8(2): p. 148-66.

61. Kuliev, A., et al., Meiosis errors in over 20,000 oocytes studied in the practice of preimplantation aneuploidy testing. Reprod Biomed Online, 2011. 22(1): p. 2-8.

62. Fragouli, E., et al., The cytogenetics of polar bodies: insights into female meiosis and the diagnosis of aneuploidy. Mol Hum Reprod, 2011. 17(5): p. 286-95.

63. Pacchierotti, F., et al., Gender effects on the incidence of aneuploidy in mammalian germ cells. Environ Res, 2007. 104(1): p. 46-69.

64. Gianaroli, L., et al., Predicting aneuploidy in human oocytes: key factors which affect the meiotic process. Hum Reprod, 2010. 25(9): p. 2374-86.

65. Verlinsky, Y., et al., Prevention of age-related aneuploidies by polar body testing of oocytes. J Assist Reprod Genet, 1999. 16(4): p. 165-9.

66. Handyside, A.H., et al., Multiple meiotic errors caused by predivision of chromatids in women of advanced maternal age undergoing in vitro fertilisation. Eur J Hum Genet, 2012. 20(7): p. 742-7.

67. Jones, K.T. and S.I.R. Lane, Molecular causes of aneuploidy in mammalian eggs. Development, 2013. 140(18): p. 3719-3730.

68. Duncan, F.E., et al., Chromosome cohesion decreases in human eggs with advanced maternal age. Aging Cell, 2012. 11(6): p. 1121-4.

69. Chiang, T., et al., Evidence that weakened centromere cohesion is a leading cause of age-related aneuploidy in oocytes. Curr Biol, 2010. 20(17): p. 1522-8.

70. Lagirand-Cantaloube, J., et al., Loss of Centromere Cohesion in Aneuploid Human Oocytes Correlates with Decreased Kinetochore Localization of the Sac Proteins Bub1 and Bubr1. Sci Rep, 2017. 7: p. 44001.

71. Burkhardt, S., et al., Chromosome Cohesion Established by Rec8-Cohesin in Fetal Oocytes Is Maintained without Detectable Turnover in Oocytes Arrested for Months in Mice. Curr Biol, 2016. 26(5): p. 678-85.

72. Toth, A. and R. Jessberger, Oogenesis: Ageing Oocyte Chromosomes Rely on Amazing Protein Stability. Curr Biol, 2016. 26(8): p. R329-31.

73. Revenkova, E., et al., Oocyte cohesin expression restricted to predictyate stages provides full fertility and prevents aneuploidy. Curr Biol, 2010. 20(17): p. 1529-33.

74. Tachibana-Konwalski, K., et al., Rec8-containing cohesin maintains bivalents without turnover during the growing phase of mouse oocytes. Genes Dev, 2010. 24(22): p. 2505-16.

75. Perkins, A.T., et al., Oxidative stress in oocytes during midprophase induces premature loss of cohesion and chromosome segregation errors. Proc Natl Acad Sci U S A, 2016. 113(44): p. E6823-E6830.

76. Park, Y.S., et al., Eccentric localization of catalase to protect chromosomes from oxidative damages during meiotic maturation in mouse oocytes. Histochem Cell Biol, 2016. 146(3): p. 281-8.

77. Cheng, J.M., et al., Elevated intracellular pH appears in aged oocytes and causes oocyte aneuploidy associated with the loss of cohesion in mice. Cell Cycle, 2016. 15(18): p. 2454-63.

78. Spits, C., et al., Chromosome constitution of human embryos generated after in vitro maturation including 3-isobutyl-1-methylxanthine in the oocyte collection medium. Hum Reprod, 2015. 30(3): p. 653-63.

79. Shirasawa, H. and Y. Terada, In vitro maturation of human immature oocytes for fertility preservation and research material. Reproductive Medicine and Biology, 2017. 16(3): p. 258-267.

80. Fesahat, F., et al., The effects of different types of media on in vitro maturation outcomes of human germinal vesicle oocytes retrieved in intracytoplasmic sperm injection cycles. Clin Exp Reprod Med, 2017. 44(2): p. 79-84.

81. Khalili, M.A., et al., Contribution of human oocyte architecture to success of in vitro maturation technology. Iran J Reprod Med, 2013. 11(1): p. 1-10.

82. Imesch, P., et al., Developmental potential of human oocytes matured in vitro followed by vitrification and activation. J Ovarian Res, 2013. 6: p. 30.

83. Trounson, A., C. Anderiesz, and G. Jones, Maturation of human oocytes in vitro and their developmental competence. Reproduction, 2001. 121(1): p. 51-75.

84. Li, G.P., et al., Mouse-rabbit germinal vesicle transfer reveals that factors regulating oocyte meiotic progression are not species-specific in mammals. J Exp Zool, 2001. 289(5): p. 322-9.

85. Kyogoku, H. and T.S. Kitajima, Large Cytoplasm Is Linked to the Error-Prone Nature of Oocytes. Dev Cell, 2017. 41(3): p. 287-298 e4.

86. Tartia, A.P., et al., Cell volume regulation is initiated in mouse oocytes after ovulation. Development, 2009. 136(13): p. 2247-54.

87. Inoue, A., et al., The perivitelline space-forming capacity of mouse oocytes is associated with meiotic competence. J Reprod Dev, 2007. 53(5): p. 1043-52.

88. Baltz, J.M. and A.P. Tartia, Cell volume regulation in oocytes and early embryos: connecting physiology to successful culture media. Hum Reprod Update, 2010. 16(2): p. 166-76.

89. Takeuchi, T., et al., A reliable technique of nuclear transplantation for immature mammalian oocytes. Hum Reprod, 1999. 14(5): p. 1312-7.

90. Cui, L.B., X.Y. Huang, and F.Z. Sun, Transfer of germinal vesicle to ooplasm of young mice could not rescue ageing-associated chromosome misalignment in meiosis of oocytes from aged mice. Hum Reprod, 2005. 20(6): p. 1624-31.

91. Liu, L. and D.L. Keefe, Nuclear origin of aging-associated meiotic defects in senescence-accelerated mice. Biol Reprod, 2004. 71(5): p. 1724-9.

92. Cha, K.Y., et al., Pregnancy after in vitro fertilization of human follicular oocytes collected from nonstimulated cycles, their culture in vitro and their transfer in a donor oocyte program. Fertil Steril, 1991. 55(1): p. 109-13.

93. Dahan, M.H., et al., Clinical definition paper on in vitro maturation of human oocytes. Hum Reprod, 2016. 31(7): p. 1383-6.

94. Holubcova, Z., et al., Human oocytes. Error-prone chromosome-mediated spindle assembly favors chromosome segregation defects in human oocytes. Science, 2015. 348(6239): p. 1143-7.

95. Yu, Y., et al., Effects of combined epidermal growth factor, brain-derived neurotrophic factor and insulin-like growth factor-1 on human oocyte maturation and early fertilized and cloned embryo development. Hum Reprod, 2012. 27(7): p. 2146-59.

96. Sanchez, F., et al., An improved IVM method for cumulus-oocyte complexes from small follicles in polycystic ovary syndrome patients enhances oocyte competence and embryo yield. Hum Reprod, 2017. 32(10): p. 2056-2068.

97. Liu, J., et al., Successful in vitro maturation of human oocytes not exposed to human chorionic gonadotropin during ovulation induction, resulting in pregnancy. Fertil Steril, 1997. 67(3): p. 566-8.

98. Barnes, F.L., et al., Production of embryos from in vitro-matured primary human oocytes. Fertil Steril, 1996. 65(6): p. 1151-6.

99. Cavilla, J.L., et al., Human immature oocytes grow during culture for IVM. Hum Reprod, 2008. 23(1): p. 37-45.

100. Walls, M.L., et al., Structural and morphologic differences in human oocytes after in vitro maturation compared with standard in vitro fertilization. Fertil Steril, 2016. 106(6): p. 1392-1398 e5.

101. Brison, D.R., et al., Identification of viable embryos in IVF by non-invasive measurement of amino acid turnover. Hum Reprod, 2004. 19(10): p. 2319-24.

102. Jones, G.M., et al., Gene expression profiling of human oocytes following in vivo or in vitro maturation. Hum Reprod, 2008. 23(5): p. 1138-44.

103. Coticchio, G., et al., Ultrastructure of human oocytes after in vitro maturation. Mol Hum Reprod, 2016. 22(2): p. 110-8.

104. Farsi, M.M., N. Kamali, and M. Pourghasem, Embryological aspects of oocyte in vitro maturation. Int J Mol Cell Med, 2013. 2(3): p. 99-109.

105. Son, W.Y., et al., Comparison of fertilization and embryonic development in sibling in vivo matured oocytes retrieved from different sizes follicles from in vitro maturation cycles. J Assist Reprod Genet, 2011. 28(6): p. 539-44.

106. Son, W.Y., et al., Selection of the optimal day for oocyte retrieval based on the diameter of the dominant follicle in hCG-primed in vitro maturation cycles. Hum Reprod, 2008. 23(12): p. 2680-5.

107. Cohen, J., et al., Ooplasmic transfer in mature human oocytes. Mol Hum Reprod, 1998. 4(3): p. 269-80.

108. Kang, E., et al., Mitochondrial replacement in human oocytes carrying pathogenic mitochondrial DNA mutations.Nature, 2016. 540(7632): p. 270-275.

109. Yamada, M., et al., Genetic Drift Can Compromise Mitochondrial Replacement by Nuclear Transfer in Human Oocytes. Cell Stem Cell, 2016. 18(6): p. 749-54.